Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial
Keisuke Anan, Yuki Kataoka, Masataka Taguri, Kazuya Ichikado, Ryo Tachikawa, Kazunori Tobino, Kodai Kawamura, Chigusa Shirakawa, Takafumi Kawabata, Yosuke Yamamoto · 2026
Read Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial by Keisuke Anan, Yuki Kataoka, Masataka Taguri, Kazuya Ichikado, Ryo Tachikawa, Kazunori Tobino, Kodai Kawamura, Chigusa Shirakawa, Takafumi Kawabata, Yosuke Yamamoto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13331100.txt.
Description
Keisuke Anan and colleagues set out a trial protocol on steroid tapering for sudden worsening of lung scarring in 2026. Acute flare of idiopathic pulmonary fibrosis kills often, and steroids are standard despite thin trial proof. Whether faster dose cuts match usual care is unknown. The RAPID-IPF trial runs across centres in Japan.
Patients in hospital will be split evenly between a fast 6-week prednisolone taper and a standard 12-week taper. The main outcome is death from any cause at 90 days, tested against a set fairness margin. Early enrolment targets 70 patients, rising to 130 at most in the plan. Two interim checks will test feasibility and resize the trial.
Catalog record
| CREATOR | Keisuke Anan, Yuki Kataoka, Masataka Taguri, Kazuya Ichikado, Ryo Tachikawa, Kazunori Tobino, Kodai Kawamura, Chigusa Shirakawa, Takafumi Kawabata, Yosuke Yamamoto |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47194 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |